GemVax&KAEL Co.,Ltd.'s latest marketcap:
As of 07/28/2025, GemVax&KAEL Co.,Ltd.'s market capitalization has reached $1.62 B. According to our data, GemVax&KAEL Co.,Ltd. is the 7052th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.62 B |
| Revenue (ttm) | 43.42 M |
| Net Income (ttm) | -44,326,758.31 |
| Shares Out | 41.09 M |
| EPS (ttm) | -1.12 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/27/2007 |
| Earnings Date | 08/14/2025 |
GemVax&KAEL Co.,Ltd.'s yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | ₩2.25 T | $1.62 B | 304.44% | 7052 |
| 12/30/2024 | ₩587.26 B | $393.47 M | 12.19% | 14581 |
| 12/28/2023 | ₩523.46 B | $403.07 M | 12.46% | 14459 |
| 12/29/2022 | ₩465.48 B | $367.73 M | -32.98% | 14244 |
| 12/30/2021 | ₩694.51 B | $583.39 M | -26.38% | 12388 |
| 12/30/2020 | ₩943.35 B | $867.88 M | -36.2% | 8641 |
| 12/30/2019 | ₩1.48 T | $1.27 B | 250.72% | 5945 |
| 12/28/2018 | ₩421.59 B | $375.22 M | -3.26% | 10575 |
| 12/28/2017 | ₩435.79 B | $405.28 M | -1.52% | 11416 |
| 12/29/2016 | ₩442.51 B | $362.85 M | -32.17% | 10540 |
Company Profile
About GemVax&KAEL Co., Ltd
GemVax&KAEL Co., Ltd is a South Korean company specializing in the manufacturing and sale of high-performance materials for the semiconductor and display industries. Established in 1998 and headquartered in Daejeon, the company plays a key role in advanced technology sectors.
Core Products & Services
- Coating Resins & Filters: Supplies essential materials for semiconductor and display production.
- CA Filters & Gas Scrubber Resins: Provides pollution control solutions tailored for high-tech manufacturing environments.
Research & Development
The company is actively involved in innovative R&D, including the development of anti-cancer vaccines, showcasing its commitment to diversifying into biotechnology.
Frequently Asked Questions
-
What is GemVax&KAEL Co.,Ltd.'s (KOSDAQ-082270) current market cap?As of 07/28/2025, GemVax&KAEL Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $1.62 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GemVax&KAEL Co.,Ltd. (KOSDAQ-082270) rank globally by market cap?GemVax&KAEL Co.,Ltd. global market capitalization ranking is approximately 7052 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.